Your browser doesn't support javascript.
loading
Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma.
Deken, Marcel A; Gadiot, Jules; Jordanova, Ekaterina S; Lacroix, Ruben; van Gool, Melissa; Kroon, Paula; Pineda, Cristina; Geukes Foppen, Marnix H; Scolyer, Richard; Song, Ji-Ying; Verbrugge, Inge; Hoeller, Christoph; Dummer, Reinhard; Haanen, John B A G; Long, Georgina V; Blank, Christian U.
Afiliação
  • Deken MA; Department of Immunology, Netherlands Cancer Institute , Amsterdam, the Netherlands.
  • Gadiot J; Department of Immunology, Netherlands Cancer Institute , Amsterdam, the Netherlands.
  • Jordanova ES; Center for Gynecologic Oncology, VU University Medical Center , Amsterdam, the Netherlands.
  • Lacroix R; Department of Immunology, Netherlands Cancer Institute , Amsterdam, the Netherlands.
  • van Gool M; Department of Immunology, Netherlands Cancer Institute , Amsterdam, the Netherlands.
  • Kroon P; Department of Immunology, Netherlands Cancer Institute , Amsterdam, the Netherlands.
  • Pineda C; Department of Immunology, Netherlands Cancer Institute , Amsterdam, the Netherlands.
  • Geukes Foppen MH; Department of Medical Oncology, Netherlands Cancer Institute , Amsterdam, the Netherlands.
  • Scolyer R; Melanoma Institute Australia, The University of Sydney, and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital , NSW, Australia.
  • Song JY; Department of Animal Pathology, Netherlands Cancer Institute , Amsterdam, the Netherlands.
  • Verbrugge I; Department of Immunology, Netherlands Cancer Institute , Amsterdam, the Netherlands.
  • Hoeller C; Department of Dermatology, Medical University of Vienna , Vienna, Austria.
  • Dummer R; Department of Dermatology, University Hospital Zurich , Zurich, Switzerland.
  • Haanen JB; Department of Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Long GV; Melanoma Institute Australia, The University of Sydney, and Royal North Shore Hospital , Sydney, Australia.
  • Blank CU; Department of Immunology, Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Oncoimmunology ; 5(12): e1238557, 2016.
Article em En | MEDLINE | ID: mdl-28123875
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Oncoimmunology Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Holanda